Harvard-MIT affiliated institute evaluates potential treatment for Creutzfeldt-Jakob disease patient

A research center affiliated with Harvard and MIT has confirmed contact with the medical team of an influencer diagnosed with Creutzfeldt-Jakob disease (CJD). The institute's ability to provide effective intervention remains uncertain given the terminal nature of the neurodegenerative condition.